Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B

NCT05770895 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

BIOLOGICAL: GS-2829
BIOLOGICAL: GS-6779
BIOLOGICAL: Placebo

Sponsor

Gilead Sciences